Modular Construction Market

Modular Construction Market for Biotechnology and Pharmaceutical Industry, Distribution by Size of Facility, Type of Industry Served, Type of Modular Construct, Type of Construction Component, Purpose of Facility, Scale of Operation, Type of Product, Type of Facility, Type of Modular Construction, Type of Material Used and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

Lowest Price Guaranteed From USD 4,799
Published
February 2023
Pages
387
View Count
39593
Buy Now

Example Insights

Please scroll down

Report Description

In terms of internal rate of return (IRR), modular manufacturing facilities are less expensive than stick-built facilities, with an IRR of 11% versus 8% for stick-built facilities. This provides an excellent opportunity for business partners to optimize project costs

-- CEO, a US-based mid-sized company

Modular Construction Overview

The global modular construction market is estimated to be worth $2.5 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9.9% during the forecast period. The adoption of modular facilities is growing in the pharmaceutical industry and the modular construction market is anticipated to grow at a CAGR of 10% during the forecast period. In the past few years, modular facilities or prefabricated buildings have emerged as a promising alternative to the conventionally built pharma / biotech manufacturing facilities. Modular construction involves building of structures using prefabricated modular units, off-site, under controlled factory setting, which are later assembled on site. It is interesting to note that off-site construction can eliminate 60%-90% of the weather-related project concerns. Further, modular facilities can be built 40% faster, as compared to a conventional construction, which could take up to three years. Therefore, considering the various advantages offered by this approach, several pharmaceutical companies are now shifting their focus from conventional plants to modular facilities. Specifically, modular facility providers are catering to the needs of various players engaged in the development of therapeutics, including cell and gene therapy, biosimilars and vaccines. To provide more context, modular manufacturing includes division of individual production processes, such as fermentation, purification and formulation, into separate modules that can be easily assembled and disassembled, allowing for flexibility and scalability. In addition, modular manufacturing allows the use of smaller-scale production units, which can be more flexible and responsive to dynamic market demands. Moreover, temporary modular buildings can be relocated after installation, based on needs of the end-user. However, mass production, complex decision-making, construction approvals and early financing can hinder the adoption of modular constructs. If healthcare stakeholders are able to overcome these challenges, modular construction can serve as a lucrative approach that provides greater flexibility and enables faster time-to-market for new products.

The image provides context of modular construction market. Pre-engineered buildings, also known as modular facilities, present a promising alternative to conventional buildings; this is especially true in the healthcare sector, where cost and timelines are pivotal, while ensuring adherence to regulatory protocols

Key Market Insights

The Modular Construction Market for Biotechnology and Pharmaceutical Industry (3rd Edition), 2023-2035: Distribution by Size of Facility (Small, Mid-sized, Large and Very Large), Type of Industry Served (Pharmaceutical and Biotechnology), Type of Modular Construct (Hybrid Skid Modular Constructs, Skid-Mounted Modular Constructs, Plug-and-Play Modular Constructs, Truckable Modular Constructs and Other Modular Constructs), Type of Construction Component (Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components), Purpose of Facility (Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities and Other Facilities), Scale of Operation (Clinical and Commercial), Type of Product (Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products), Type of Expansion (New Facilities, Facility Expansions and Planned Expansions), Type of Modular Construction (Relocatable Modular Construction, Permanent Modular Construction), Type of Material Used (Steel, Wood and Concrete) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunity, offering an informed opinion on the likely adoption of modular manufacturing in the biotechnology / pharmaceutical industry, over the forecast period. The market report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry. The research report answers the following key questions related to the biopharmaceutical modular manufacturing market.

This image provides list of modular construction facility providers. Over 50 companies are currently engaged in offering modular facilities; a relatively larger proportion of these firms serve pharmaceutical client base

Key Advantages Offered by Modular Facilities

Modular facilities have emerged as a promising alternative to conventional facilities owing to the multiple benefits that they offer. For instance, modular facilities can help in achieving 25%-30% reduction in the overall cost of construction, minimal plant site interruption, 50%-60% faster construction timelines, as well as ensure portability, safe working conditions and sustainability. In addition, better quality of products can be achieved by modular construction approaches as the modules are built in a controlled factory setting. In addition, these modules are inspected more thoroughly and frequently before they are shipped to the construction site, meeting desired quality standards. Moreover, modular construction allows more flexibility in terms of design, as a higher number of materials and finishes can be used, as compared to conventional facilities.

The infographic talks about modular manufacturing market landscape. Stakeholders are catering to the demands of various industries by utilizing different types materials and delivering services globally; the market has witnessed the emergence of many new companies in recent years

Current Market Landscape of Modular Facility and Modular Cleanroom Manufacturers

The modular construction market landscape features an extensive list of over 50 large, mid-sized, small and very small manufacturers. It is worth highlighting that there are more than 250 modular cleanroom manufacturers, offering various cleanroom accessories and customization options, in order to make them suitable for application in the life sciences industry. It is expected that modular manufacturing will become more streamlined and standardized in the future, serving as an efficient cost saving solution. Additionally, modular techniques allow building of smaller and specialized processing plants whenever rapid deployment of a therapy becomes critical in both developed and developing countries. Further, many, if not most, expansions and new facilities in the biotechnology and pharmaceutical industry are likely to be modular construction in the near future.

The image provides details on modular clearnroom manufacturers. More than 255 players are engaged in providing modular cleanrooms along with associated accessories; of these, 65% are GMP certified, demonstrating the adherence to quality and industry standards

Key Drivers in the Modular Construction Market: Pharmaceutical Industry Adopting Modular Manufacturing

Over the past few years, several factors have contributed to reform the facility construction paradigm within the pharmaceutical and biotechnology industries. The increasing preference and demand for personalized therapies and novel therapeutic interventions intended for the treatment of various ailments has compelled pharmaceutical companies to look beyond the traditional manufacturing and expansion practices. Lack of adequate manufacturing infrastructure, increased cost of construction and delay in project deliveries has collectively contributed to the emergence of off-site construction models. In addition, the increased demand for vaccine manufacturing during the COVID-19 pandemic also proved to be a key growth driver for adoption of the modular clean room / prefabricated cleanrooms. In March 2021. G-CON Manufacturing delivered its prefabricated cleanroom PODs to Fujifilm Diosynth Biotechnologies for expansion of COVID-19 vaccine manufacturing at its College Station, Texas facility. Another China based modular facility manufacturer, Pharmadule Morimatsu AB delivered a modular vaccine manufacturing plant in Morocco. Funded by the Moroccan government, the plant was set up to increase the local production of vaccines. Even the growing cell and gene therapy market is adopting modular manufacturing. In May 2022, G-CON Manufacturing supplied prefabricated cleanrooms to Puerto Rico facility of CytoImmune for clinical manufacturing of NK cell-based therapies. Over the forecast period, the modular construction market for biotechnology and pharmaceutical industry is likely to grow at a healthy CAGR, as the drug manufacturers realize the benefits offered by modular manufacturing of drug facilities.

This image provides competitive intelligence on modular construction companies. In pursuit of gaining a competitive edge, stakeholders are steadily expanding their existing capabilities in order to enhance their respective service portfolios and drive compliance to evolving industry benchmarks

Global Market Size for Pharmaceutical Modular Construction

Driven by the rising interest of stakeholders towards improvement of manufacturing and production efficiency, the anticipated lucrative opportunities and growth associated with the adoption of modular facilities, the modular manufacturing market for pharmaceutical industry is expected to witness noteworthy market growth during the forecast period. Specifically, in terms of type of product, the market is anticipated to be driven by manufacturing units for cell and gene therapies, as well as vaccines and biosimilars. In addition, presently, close to 70% of the market share is captured by facility manufacturers based in North America and Europe. However, in the long run, markets in emerging regions, such as countries based in Asia, MENA and rest of the world are anticipated to grow at a faster pace.

The image talks highlights partnerships activity in the modular manufacturing space. A considerable increase in partnership activity has been witnessed since 2016; 50% of the total deals inked by modular facility providers have been focused on the construction and delivery of end-to-end facilities

Leading Modular Facilities and Modular Cleanroom Manufacturers

Examples of key companies engaged in this industry (which have also been profiled in this market report) include (in alphabetical order) Cytiva, G-Con Manufacturing, Germfree, IPM Technologies, KeyPlants, ModuleCo Pharma, NNE and Pharmadule. The report includes an easily searchable excel database of all the modular facility and modular clean room manufacturers serving the biotechnology / pharmaceutical industry worldwide.

This image highlights benefits of adopting modular facilities. Shorter construction timelines, lower financial risks and high internal rate of return are the key benefits offered by modular facilities; nearly 75% of the large modular facilities are being developed for manufacturing purposes

Recent Developments in Modular Construction Market:

Several recent developments have taken place in the field of modular construction. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

In July 2023, the Department of Biotechnology, Government of India announced that a Bio-Safety Level-3 (BSL-3) modular facility for genome sequencing will be built at the Rajiv Gandhi Centre for Biotechnology (RGCB), in Akkulam. The facility is expected to conduct research studies on BSL-3 infectious agents, including SARS-CoV-2.
In June 2023, Evotec, a leader in bioprocess development and clinical manufacturing, announced the installation of G-CON Manufacturing’s cleanroom PODs at its biologics manufacturing facility located in France.
In June 2023, C-CUBE announced that its modular cGMP manufacturing site became fully operational to expand its offerings for prefabricated modular constructions.

Scope of the Report

The market report presents an in-depth analysis of the various firms / organizations that are engaged in this industry, across different segments, as defined in the table below:

Report Attribute	Details
Base Year	2022
Forecast Period	2023 – 2035
CAGR	10%
Size of Facility	Small, Mid-sized, Large and Very Large
Type of Construction Component	Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components
Type of Facility	Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities, and Other Facilities
Scale of Operation	Clinical and Commercial
Type of Industry Served	Pharmaceutical and Biotechnology
Type of Product	Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products
Type of Facility	New Facilities, Facility Expansions and Planned Expansions
Type of Modular Construction	Permanent and Relocatable
Type of Material Used	Steel, Wood and Concrete
Key Geographical Regions	North America, Europe, Asia-Pacific, MENA and Rest of the World
Customization Scope	15% Free Customization Option
PowerPoint Presentation (Complimentary)	Available
Excel Data Packs (Complimentary)	Market Landscape Analysis, Modular Cleanroom Manufacturers Analysis, Company Competitiveness Analysis, Partnership and Collaboration Analysis, Case Study on Modular Projects Analysis, Facility Construction Trends Analysis and Market Forecast and Opportunity Analysis

The snapshot talks about future growth opportunities in modular facilities domain. In the near future, we anticipate a wider adoption of modular solutions within the pharma and biotech industry; this is also evident from recent trends on Google news

The market report features an in-depth market analysis, highlighting the capabilities of various stakeholders engaged in this market. Amongst other elements, the research report includes:

An executive summary of the key insights captured during our research, offering a high-level view on the current state of the modular manufacturing market and its likely evolution over the forecast period in the short to mid and long term.
A brief introduction to important concepts related to modular facilities, featuring information on different types of modular constructs, as well as primary applications of modular facilities in the pharmaceutical and biotechnology industry. Further, this chapter highlights the recent advancements that have been reported in this market space.
A detailed assessment of the current market landscape of modular facilities, highlighting the contributions of various service providers, along with information on their year of establishment, company size (small, mid-sized and large), location of headquarters (North America, Europe, Asia and rest of the world), type of industry served (pharmaceutical, biotechnology), geographical coverage (North America, Europe, Asia and rest of the world), GMP compliance, type of modular construction (relocatable, permanent), type of material used (steel, wood and concrete) and quality certification(s) obtained.
A detailed review of the overall landscape of the modular cleanroom manufacturers market, highlighting the contributions of various companies, along with information on their year of establishment, company size (small, mid-sized and large) , location of headquarters (North America, Europe, Asia, MENA and rest of the world), type of industry served (pharmaceutical, biotechnology), type of modular cleanroom offered (hardwall, softwall and unspecified), type of cleanroom component offered (air handling units, HEPA filters, ULPA filters, laminar air flow units, air showers, pass throughs, biosafety cabinets, cleanroom furniture, plumbing / piping, lighting / electrical, doors and windows) and quality certification(s) obtained.
An in-depth company competitiveness analysis of modular facility service providers, segmented into three categories, namely small (2-50 employees), mid-sized (51-500 employees) and large (>500 employees) players. Within the respective peer groups, companies were ranked based on various relevant parameters, such as service strength (based on the years of experience), company competitiveness (based on parameters, such as type of industry served, GMP compliance, type of modular construction and type of material used), as well as partnership activity (in terms of number of partnerships and type of agreements).
Elaborate profiles of prominent players that are currently engaged in offering modular facilities. Each profile features a brief overview of the company (with information on year of establishment, number of employees, location of headquarters and key members of the executive team), details related to their respective service portfolio, recent developments and an informed future outlook.
An analysis of the partnerships inked between various stakeholders in this industry, during the period 2012-2022, featuring a detailed set of analyses based on various parameters, such as year of partnership, type of partnership, type of product, type of modular facility, location of modular facility, geographical location of the companies involved and most active players.
A detailed case study on modular projects undertaken by modular facility manufacturers in the pharmaceutical and biotechnology industry, along with information on type of modular facility, size of modular facility, number of projects delivered and location of modular facility.
An insightful analysis on facility construction trends observed in the pharmaceutical industry over the last seven years, highlighting facility construction projects established by top 20 pharma / biotech players, along with the information on number of facilities, type of facility, purpose of facility, investments made in modular projects, size of facility and location of headquarters.
An insightful framework that enables a thorough examination of the cost and time related benefits offered by the use of different modular approaches, by considering multiple parameters, including long-term benefits and sustainability, to identify the most appropriate solution for various types of end users and enabling them to make informed decisions.
A detailed market forecast analysis to estimate the existing market size and the future opportunity for modular construction manufacturers, till 2035; the overall opportunity has been distributed across various segments, such as size of facility (small, mid-sized, large and very large), type of industry served (pharmaceutical and biotechnology), type of modular construct (hybrid skid modular constructs, skid-mounted modular constructs, plug-and-play modular constructs, truckable modular constructs and other modular constructs), type of construction component (process equipment, base building, mechanical, electrical and plumbing system, process commodities and other construction components), purpose of facility (manufacturing facilities, aseptic filling facilities, research and development facilities and other facilities), scale of operation (clinical and commercial), type of product (cell and gene therapies, vaccines, biosimilars, monoclonal antibodies, advanced pharmaceuticals, sterile products, viral vectors and other products), type of expansion (new facilities, facility expansions and planned expansions), type of modular construction (relocatable modular construction, permanent modular construction), type of material used (steel, wood and concrete) and key geographical regions (North America, Europe, Asia, Middle East And North Africa, and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
A review of emerging industry trends, including the combination of single-use technologies / continuous processing technologies with modular facilities, the shift to using smaller, multi-purpose modular facilities, and technological advancements in modular construction processes.
A detailed discussion on the various market growth drivers, such as development of personalized medicines, biosimilars, orphan drugs and anticipated increase in the adoption of modular solutions in the emerging markets by pharmaceutical / biopharmaceutical CMOs.

The infographic highlights likely growth scenarios for modular manufacturing market. Modular facilities market is anticipated to register a growth rate of ~10% in the next decade; such facilities, of varying sizes, are likely to be set up for aseptic filling, manufacturing, R&D and other purposes

The opinions and insights presented in the market report were influenced by discussions held with senior stakeholders in the industry. The market research report features detailed transcripts of interviews held with the following industry stakeholders:

Maik Jornitz (Chief Executive Officer, G-Con Manufacturing)
Pär Almhem (President, ModWave)
Vernon Solomon (President, Environmental Systems Corporation)
François Abiven (Ex-President Life Sciences and Chemicals, Exyte)
Mark Koers (Executive Vice President, Sales and Marketing, Modular Devices)
Luca Mussati (Vice President Pharmaceutical and Biotechnology, Exyte)
Ward Patton (Director of Sales, Subzero Engineering)
Wes Temple (Director of Marketing, Vernick)
Sulogna Roy (Ex-Sales Manager, Zeton)
Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market report are in USD, unless otherwise specified.

The image looks at the opportunities in modular manufacturing market. The overall market revenues are likely to be driven by modular facility construction projects focused on cell and gene therapies, vaccines, biosimilars, monoclonal antibodies and other products

Frequently Asked Questions

Question 1: What is modular manufacturing?

Answer: Modular manufacturing involves manufacturing of prefabricated buildings that are built using multiple sections, often known as modules

Question 2: What is the modular facility manufacturing process?

Answer: Modular constructs are designed, engineered and manufactured off-site, and later delivered to relevant project site for final installation. Further, integrated assemblies are joined together to create facilities of significant size, housing multiple functions and equipment.

Question 3: Which material is most widely used for the modular construction of pharmaceutical facilities?

Answer: Steel and wood are the most commonly used materials for building pre-engineered builds. Of these, steel is usually employed to construct permanent buildings since they are built for use over longer periods of time. On the other hand, wood is generally more suitable for building relocatable constructs as the material is lightweight and hence, allows easy relocation.

Question 4: Which healthcare sector is rapidly employing modular facilities?

Answer: Currently, the pharmaceutical industry is leading the adoption of modular facilities in the healthcare sector. On the other hand, the modular construction market for biotechnology industry is expected to grow at 11%, capturing a considerable market share in the foreseen future.

Question 5: Which types of partnerships are inked by modular facility providers?

Answer: Full facility construction agreements, service alliances and cleanroom construction agreements are the most common partnership models adopted by stakeholders engaged in the modular facilities domain.

Question 6: How is the modular construction market within pharmaceutical industry likely to grow in the future?

Answer: The global modular construction market is anticipated to grow at a compound annualized growth rate (CAGR) of 10%, during the forecast period.

Question 7: Which region is leading the modular construction market (biotechnology / pharmaceutical industry)?

Answer: North America and Europe, combined, hold 70% share of the global modular construction market. In the longer run, emerging regions, such as Asia, are likely to grow at faster pace.

Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process

3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction

3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects

4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served

5. MARKET LANDSCAPE: MODULAR CLEANROOM MANUFACTURERS
5.1. Chapter Overview
5.2. Modular Cleanroom Manufacturers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained

6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook

7.3. G-Con Manufacturing
7.3.1. Company Overview
7.3.2. Modular Facility-related Services
7.3.3. Modular Projects
7.3.4. Recent Developments and Future Outlook

7.4. Germfree
7.4.1. Company Overview
7.4.2. Modular Facility-related Services
7.4.3. Modular Projects
7.4.4. Recent Developments and Future Outlook

7.5. IPM Technologies
7.5.1. Company Overview
7.5.2. Modular Facility-related Services
7.5.3. Modular Projects
7.5.4. Recent Developments and Future Outlook

7.6. KeyPlants
7.6.1. Company Overview
7.6.2. Modular Facility-related Services
7.6.3. Modular Projects
7.6.4. Recent Developments and Future Outlook

7.7. ModuleCo Pharma
7.7.1. Company Overview
7.7.2. Modular Facility-related Services
7.7.3. Modular Projects
7.7.4. Recent Developments and Future Outlook

7.8. NNE
7.8.1. Company Overview
7.8.2. Modular Facility-related Services
7.8.3. Modular Projects
7.8.4. Recent Developments and Future Outlook

7.9. Pharmadule
7.9.1. Company Overview
7.9.2. Modular Facility-related Services
7.9.3. Modular Projects
7.9.4. Recent Developments and Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country

9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Versus Conventional Construction Methods
9.3. Return on Investment
9.4. Case Study: Facility Based on KUBio Platform
9.4.1. Cytiva KUBio Platform: Overview
9.4.2. Eden Biologics Kubio Modular Project in China: Overview and Construction Details
9.5. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.5.1. Analysis by Type of Modular Facility
9.5.2. Analysis by Size of Modular Facility
9.5.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.5.4. Leading Clients: Analysis by Number of Projects Received
9.5.5. Analysis by Location of Modular Facility
9.5.6. Analysis by Type of Facility and Size of Modular Facility
9.5.7. Analysis by Client and Location of Facility

10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility

11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Parameters
11.3. Key Assumptions and Methodology
11.4. Comparison of Intrinsic Factors
11.4.1. Analysis by Type of Material Used
11.4.2. Analysis by Type of Modular Construction
11.4.1. Analysis by Purpose of Facility
11.4.2. Analysis by Geographical Location
11.5. Integrated Outcome Modeling – Scenario Analysis
11.6. Integrated Outcome Modeling – Output Analysis
11.7. Concluding Remarks

12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Construction Market in the Pharmaceutical / Biotechnology Sector, 2023-2035
12.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-203
12.4.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035
12.4.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035
12.4.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035

12.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Construction Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Construction Market in the Biotechnology Industry, 2023-2035

12.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035

12.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035
12.7.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Buildings, 2023-2035
12.7.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035
12.7.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035

12.8 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing, 2023-2035
12.8.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling, 2023-2035
12.8.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development, 2023-2035
12.8.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Purposes, 2023-2035

12.9. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Scale, 2023-2035
12.9.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Scale, 2023-2035

12.10. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035
12.10.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035
12.10.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035
12.10.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035
12.10.8. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035

12.11. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035
12.11.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035
12.11.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035

12.12. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035

12.13. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035
12.13.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035
12.13.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035

12.14. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Geography, 2023 and 2035
12.14.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035
12.14.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035
12.14.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035
12.14.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035
12.14.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035

12.15. Concluding Remarks

13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies

14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions

15. CONCLUSION

16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.1. Company Snapshot
16.2.2. Interview Transcript: Alan de Zayas (Modular Building Manufacturing and Construction Team)

16.3. Environmental Systems Corporation
16.3.1. Company Snapshot
16.3.2. Interview Transcript: Vernon Solomon (President)

16.4. Exyte
16.4.1. Company Snapshot
16.4.2. Interview Transcript: François Abiven (Executive Vice President Global Business Unit BLS) and Luca Mussati (Vice President Technology and Innovation)

16.5. G-Con Manufacturing
16.5.1. Company Snapshot
16.5.2. Interview Transcript: Maik Jornitz (Chief Executive Officer)

16.6. Modular Devices
16.6.1. Company Snapshot
16.6.2. Interview Transcript: Mark Koers (Executive Vice President, Sales and Marketing)

16.7. ModWave
16.7.1. Company Snapshot
16.7.2. Interview Transcript: Pär Almhem (President)

16.8. Subzero Engineering
16.8.1. Company Snapshot
16.8.2. Interview Transcript: Ward Patton (Director of Sales)

16.9. Vernick
16.9.1. Company Snapshot
16.9.2. Interview Transcript: Wes Temple (Director of Marketing)

16.10. Zeton
16.10.1. Company Snapshot
16.10.2. Interview Transcript: Sulogna Roy (Ex-Sales Manager)

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Modular Facility Manufacturers
Figure 2.2 Executive Summary: Modular Cleanroom Manufacturers
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
Figure 2.5 Executive Summary: Facility Construction Trends in the Pharmaceutical Industry
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Modular Construction: Applications
Figure 3.2 Modular Construction: Processes Involved
Figure 3.3 Modular and Conventional Buildings: Construction Timeline
Figure 3.4 Modular Construction: Advantages
Figure 4.1 Modular Facility Manufacturers: Distribution by Year of Establishment
Figure 4.2 Modular Facility Manufacturers: Distribution by Company Size
Figure 4.3 Modular Facility Manufacturers: Distribution by Location of Headquarters
Figure 4.4 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Figure 4.5 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 4.6 Modular Facility Manufacturers: Distribution by Type of Industry Served
Figure 4.7 Modular Facility Manufacturers: Distribution by Geographical Coverage
Figure 4.8 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
Figure 4.9 Modular Facility Manufacturers: Distribution by GMP Compliance
Figure 4.10 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
Figure 4.11 Modular Facility Manufacturers: Distribution by Type of Modular Construction
Figure 4.12 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
Figure 4.13 Modular Facility Manufacturers: Distribution by Type of Material Used
Figure 4.14 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material Used
Figure 4.15 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
Figure 5.1 Modular Cleanroom Manufacturers: Distribution by Year of Establishment
Figure 5.2 Modular Cleanroom Manufacturers: Distribution by Company Size
Figure 5.3 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters
Figure 5.4 Modular Cleanroom Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Figure 5.5 Modular Cleanroom Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 5.6 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served
Figure 5.7 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Location of Headquarters
Figure 5.8 Modular Cleanroom Manufacturers: Distribution by Type of Modular Cleanroom Offered
Figure 5.9 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
Figure 5.10 Modular Cleanroom Manufacturers: Distribution by Type of Cleanroom Component Offered
Figure 5.11 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Cleanroom Component Offered
Figure 5.12 Modular Cleanroom Manufacturers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
Figure 5.13 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
Figure 5.14 Modular Cleanroom Manufacturers: Distribution by Quality Certifications Obtained
Figure 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
Figure 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Figure 6.3 Company Competitiveness Analysis: Small Companies
Figure 6.4 Company Competitiveness Analysis: Mid-sized Companies
Figure 6.5 Company Competitiveness Analysis: Large Companies
Figure 7.1 Cytiva: Stages of KUBio Facility Project
Figure 7.2 Germfree: Types of Lab Modules
Figure 7.3 IPM Technologies: Features of ISOdule Units
Figure 7.4 IPM Technologies: Applications of Modular Facilities
Figure 7.5 KeyPlants: Modular Facility-related Services
Figure 7.6 NNE: Modular Facility-related Services
Figure 7.7 NNE: Benefits of Bio on Demand Facility
Figure 7.8 Pharmadule: Modular Facility Services
Figure 7.9 Pharmadule: Process of Modular Facility Construction
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Modular Facility
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Distribution by Location of Partner’s Headquarters
Figure 8.10 Partnerships and Collaborations: Distribution by Location of Modular Facility
Figure 8.11 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
Figure 8.12 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
Figure 8.13 Intercontinental and Intracontinental Partnerships
Figure 8.14 Partnerships and Collaborations: Country-wise Distribution
Figure 9.1 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Modular versus Conventional Construction Methods
Figure 9.2 Modular and Conventional Facilities: Comparison of Construction Timelines
Figure 9.3 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: KUBio Facility Construction Timeline
Figure 9.4 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Modular Facility
Figure 9.5 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Size of Modular Facility
Figure 9.6 Most Active Manufacturers: Distribution by Number of Projects Delivered
Figure 9.7 Most Active Clients: Distribution by Number of Projects Received
Figure 9.8 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Location of Modular Facility
Figure 9.9 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Facility and Size of Modular Facility
Figure 10.1 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
Figure 10.2 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
Figure 10.3 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
Figure 10.4 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
Figure 10.5 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
Figure 10.6 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
Figure 10.7 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
Figure 10.8 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
Figure 10.9 Facility Construction Trends in the Pharmaceutical Industry: Purpose of Facility and Size of Facility
Figure 10.10 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
Figure 10.11 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
Figure 10.12 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
Figure 11.1 Cost, Time Optimization Framework: Impact of Type of Material
Figure 11.2 Cost, Time Optimization Framework: Impact of Type of Modular Construction
Figure 11.3 Cost, Time Optimization Framework: Impact of Purpose of Facility
Figure 11.4 Cost, Time Optimization Framework: Impact of Geographical Location
Figure 11.5 Integrated Outcome Modeling – Scenario Analysis
Figure 11.5 Integrated Outcome Modeling – Output Analysis
Figure 12.1 Global Modular Construction Market in the Pharmaceutical / Biotechnology Industry, 2023-2035 (USD Million)
Figure 12.2 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Size of Facility, 2023 and 2035
Figure 12.3 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-2035 (USD Million)
Figure 12.4 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035 (USD Million)
Figure 12.5 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035 (USD Million)
Figure 12.6 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035 (USD Million)
Figure 12.7 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Industry Served, 2023 and 2035
Figure 12.8 Modular Construction Market in the Pharmaceutical Industry, 2023-2035 (USD Million)
Figure 12.9 Modular Construction Market in the Biotechnology Industry, 2023-2035 (USD Million)
Figure 12.10 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Modular Construct, 2023 and 2035
Figure 12.11 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035 (USD Million)
Figure 12.12 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035 (USD Million)
Figure 12.13 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035 (USD Million)
Figure 12.14 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035 (USD Million)
Figure 12.15 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035 (USD Million)
Figure 12.16 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Construction Component, 2023 and 2035
Figure 12.17 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035 (USD Million)
Figure 12.18 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Building, 2023-2035 (USD Million)
Figure 12.19 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing System, 2023-2035 (USD Million)
Figure 12.20 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035 (USD Million)
Figure 12.21 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035 (USD Million)
Figure 12.22 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Purpose of Facility, 2023 and 2035
Figure 12.23 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing Facilities, 2023-2035 (USD Million)
Figure 12.24 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling Facilities, 2023-2035 (USD Million)
Figure 12.25 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development Facilities, 2023-2035 (USD Million)
Figure 12.26. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Facilities, 2023-2035 (USD Million)
Figure 12.27 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Scale of Operation, 2023 and 2035
Figure 12.28 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Operations, 2023-2035 (USD Million)
Figure 12.29 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Operations, 2023-2035 (USD Million)
Figure 12.30 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Product, 2023 and 2035
Figure 12.31 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035 (USD Million)
Figure 12.32 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035 (USD Million)
Figure 12.33 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035 (USD Million)
Figure 12.34 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035 (USD Million)
Figure 12.35 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035 (USD Million)
Figure 12.36 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035 (USD Million)
Figure 12.37 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035 (USD Million)
Figure 12.38 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035 (USD Million)
Figure 12.39 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Facility, 2023 and 2035
Figure 12.40 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035 (USD Million)
Figure 12.41 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035 (USD Million)
Figure 12.42 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035 (USD Million)
Figure 12.43 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Modular Construction, 2023 and 2035
Figure 12.44 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035 (USD Million)
Figure 12.45 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035 (USD Million)
Figure 12.46 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Material Used, 2023 and 2035
Figure 12.47 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035 (USD Million)
Figure 12.48 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035 (USD Million)
Figure 12.49 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035 (USD Million)
Figure 12.50 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Geography, 2023 and 2035
Figure 12.51 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035 (USD Million)
Figure 12.52 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035 (USD Million)
Figure 12.53 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035 (USD Million)
Figure 12.54 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.55 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035 (USD Million)
Figure 14.1 Modular Construction Market: Future Growth Opportunities
Figure 15.1 Concluding Remarks: Modular Facility Manufacturers Market Landscape
Figure 15.2 Concluding Remarks: Company Competitiveness Analysis
Figure 15.3 Concluding Remarks: Partnerships and Collaborations
Figure 15.4 Concluding Remarks: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
Figure 15.5 Concluding Remarks: Facility Construction Trends in Pharmaceutical Industry
Figure 15.6 Concluding Remarks: Market Forecast

List Of Tables

Table 3.1 Cleanroom Classification Standards
Table 3.2 ISO and FED STD 209E: Cleanroom Classification
Table 4.1 Modular Facility Manufacturers: List of Service Providers
Table 4.2 Modular Facility Manufacturers: Information on Type of Industry Served, GMP Compliance and Geographical Coverage
Table 4.3 Modular Facility Manufacturers: Information on Type of Modular Construction and Type of Material Used
Table 4.4 Modular Facility Manufacturers: List of Quality Certifications Obtained
Table 5.1 Modular Cleanroom Manufacturers: List of Companies
Table 5.2 Modular Cleanroom Manufacturers: Type of Industry Served
Table 5.3 Modular Cleanroom Manufacturers: Type of Modular Cleanroom Offered
Table 5.4 Modular Cleanroom Manufacturers: Type of Cleanroom Component Offered
Table 5.5 Modular Cleanroom Manufacturers: List of Regulatory Approvals and Certifications Obtained
Table 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
Table 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Table 6.3 Company Competitiveness Analysis: List of Small players
Table 6.4 Company Competitiveness Analysis: List of Mid-sized players
Table 6.5 Company Competitiveness Analysis: List of Large players
Table 7.1 List of Companies Profiled
Table 7.2 Cytiva: Key Highlights
Table 7.3 Cytiva: Modular Facility-Related Services
Table 7.4 Cytiva: Single-Use Technology Portfolio
Table 7.5 Cytiva: Modular Projects
Table 7.6 Cytiva: Recent Developments and Future Outlook
Table 7.7 G-Con Manufacturing: Key Highlights
Table 7.8 G-Con Manufacturing: Modular Facility-Related Services
Table 7.9 G-Con Manufacturing: Modular Projects
Table 7.10 G-Con Manufacturing: Recent Developments and Future Outlook
Table 7.11 Germfree: Key Highlights
Table 7.12 Germfree: Modular Facility-Related Services
Table 7.13 Germfree: Key Features of Modules
Table 7.14 Germfree: Recent Developments and Future Outlook
Table 7.15 IPM Technologies: Key Highlights
Table 7.16 IPM Technologies: Types of Modular Production Units
Table 7.17 KeyPlants: Key Highlights
Table 7.18 KeyPlants: Recent Developments and Future Outlook
Table 7.19 ModuleCo Pharma: Key Highlights
Table 7.20 ModuleCo Pharma: Key Features of Modular Facilities
Table 7.21 NNE: Key Highlights
Table 7.22 NNE: Modular Projects
Table 7.23 NNE: Recent Developments and Future Outlook
Table 7.24 Pharmadule: Key Highlights
Table 7.25 Pharmadule: Modular Projects
Table 7.26 Pharmadule: Recent Developments and Future Outlook
Table 8.1 Modular Facility Manufacturers: List of Partnerships and Collaborations, 2012-2022
Table 8.2 Modular Facility Manufacturers: List of Partnerships and Collaborations, Information on Type of Agreement 2012-2022
Table 9.1 Modular Facilities and Conventional Facilities: Comparison of Construction Investment and Financial Returns
Table 9.2 Modular Facilities: List of Modular Projects
Table 9.3 Modular Facilities: List of Clients and Location of Facility
Table 10.1 Conventional Facilities: Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry (Top 20 Companies): Historical Data, January 2016-2022
Table 10.2 Conventional Facilities: Information on Location of Headquarters, Area of Facility and Size of Facility
Table 13.1 Modular Facilities: Technological Advancements
Table 16.1 Avon Modular: Company Snapshot
Table 16.2. Environmental Systems Corporation: Company Snapshot
Table 16.3 Exyte: Company Snapshot
Table 16.4 G-Con Manufacturing: Company Snapshot
Table 16.5 Modular Devices: Company Snapshot
Table 16.6 ModWave: Company Snapshot
Table 16.7 Subzero Simplex Cleanrooms: Company Snapshot
Table 16.8 Vernick Cleanroom Design and Construction: Company Snapshot
Table 16.9 Zeton: Company Snapshot
Table 17.1 Modular Facility Manufacturers: Distribution by Year of Establishment
Table 17.2 Modular Facility Manufacturers: Distribution by Company Size
Table 17.3 Modular Facility Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 17.4 Modular Facility Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 17.5 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Table 17.6 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
Table 17.7 Modular Facility Manufacturers: Distribution by Type of Industry Served
Table 17.8 Modular Facility Manufacturers: Distribution by Geographical Coverage
Table 17.9 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
Table 17.10 Modular Facility Manufacturers: Distribution by GMP Compliance
Table 17.11 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
Table 17.12 Modular Facility Manufacturers: Distribution by Type of Modular Construction
Table 17.13 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
Table 17.14 Modular Facility Manufacturers: Distribution by Type of Material Used
Table 17.15 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material Used
Table 17.16 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
Table 17.17 Modular Cleanroom Manufacturers: Distribution by Year of Establishment
Table 17.18 Modular Cleanroom Manufacturers: Distribution by Company Size
Table 17.19 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 17.20 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 17.21 Modular Cleanroom Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Table 17.22 Modular Cleanroom Manufacturers: Distribution by Company Size and Location of Headquarters
Table 17.23 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served
Table 17.24 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Location of Headquarters
Table 17.25 Modular Cleanroom Manufacturers: Distribution by Type of Modular Cleanroom Offered
Table 17.26 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
Table 17.27 Modular Cleanroom Manufacturers: Distribution by Type of Cleanroom Component Offered
Table 17.28 Modular Cleanroom Manufacturers: Distribution by Type of Industry Served and Cleanroom Component Offered
Table 17.29 Modular Cleanroom Manufacturers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
Table 17.30 Modular Cleanroom Manufacturers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
Table 17.31 Modular Cleanroom Manufacturers: Distribution by Quality Certifications Obtained
Table 17.32 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
Table 17.33 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.34 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Table 17.35 Partnerships and Collaborations: Distribution by Type of Product
Table 17.36 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Table 17.37 Partnerships and Collaborations: Distribution by Type of Modular Facility
Table 17.38 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
Table 17.39 Most Active Players: Distribution by Number of Partnerships
Table 17.40 Partnerships and Collaborations: Distribution by Location of Partner’s Headquarters
Table 17.41 Partnerships and Collaborations: Distribution by Location of Modular Facility
Table 17.42 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
Table 17.43 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
Table 17.44 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 17.45 Partnerships and Collaborations: Location of Headquarters (Country-wise) Distribution
Table 17.46 Modular Facilities: Distribution by Type of Modular Facility
Table 17.47 Modular Facilities: Distribution by Size of Facility
Table 17.48 Most Active Manufacturers: Distribution by Number of Projects Delivered
Table 17.49 Most Active Clients: Distribution by Number of Projects Received
Table 17.50 Modular Facilities: Distribution by Location of Modular Facility
Table 17.51 Modular Facilities: Distribution by Type of Facility and Size of Modular Facility
Table 17.52 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
Table 17.53 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
Table 17.54 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
Table 17.55 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
Table 17.56 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
Table 17.57 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
Table 17.58 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
Table 17.59 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
Table 17.60 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Size of Facility
Table 17.61 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
Table 17.62 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
Table 17.63 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
Table 17.64 Global Modular Construction Market in the Pharmaceutical / Biotechnology Industry, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 17.65 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Size of Facility, 2023 and 2035
Table 17.66 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.67 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.68 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.69 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.70 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Industry Served, 2023 and 2035
Table 17.71 Modular Construction Market in the Pharmaceutical Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.72 Modular Construction Market in the Biotechnology Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.73 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Modular Construct, 2023 and 2035
Table 17.74 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.75 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.76 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.77 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.78 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.79 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Construction Component, 2023 and 2035
Table 17.80 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.81 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Building, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.82 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing System, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.83 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.84 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.85 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Purpose of Facility, 2023 and 2035
Table 17.86 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.87 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.88 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.89 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Facilities, 2023-2035, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.90 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Scale of Operation, 2023 and 2035
Table 17.91 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.92 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.93 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Product, 2023 and 2035
Table 17.94 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.95 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.96 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.97 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.98 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.99 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.100 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.101 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.102 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Expansion, 2023 and 2035
Table 17.103 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.104 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.105 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.106 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Modular Construction, 2023 and 2035
Table 17.107 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.108 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.109 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Type of Material Used, 2023 and 2035
Table 17.110 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.111 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.112 Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.113 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Distribution by Geography, 2023 and 2035
Table 17.114 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.115 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.116 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.117 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.118 Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

209Technologies
3P Biopharmaceuticals
A.D. Clean Rooms
Ab Biotechnology
Abbott
AbbVie
ABN Cleanroom Technology
Abtech
Abzena
ACH Engineering
ACIC Machinery
ACME Cleanroom Technologies
Acumen Technology
Adamson Pharma
ADC Biotechnology
ADK Modulraum
AdvanceTEC
AES Clean Technology
Air Micron Cleantech
Aircare Projects
Airgas
AirKey
Airology
Airplan
Airtech Systems
Ajinomoto
Albian Group
Alfa PEB
Allied Cleanrooms
AM Technical Solutions
American Cleanroom Systems
Amgen
Amicron Cleantech
Amperox
Angstrom Technology
Anker Projects
APsystems
Aprotech
Ardmac
Asgard Cleanroom Solutions
AstraZeneca
Atmos Tech Industries
Autolus Therapeutics
AveXis
Avid Bioservices
Avon Modular
AWS Bio-Pharma Technologies
Axenic Systems
B. Braun Medical
Balaji CleanAir Solutions
Bangalore Air Tech Solution
Bassaire
Baxter
Bayer
BC Technology
BeiGene
Belcher Equipment
bioBUBBLE
Biocatalysts
Bio Clean Integrated Air System
BioCon Solutions
Biofactory Competence Center
Biogen
Biologics Modular
BM Engineering
Bode Equipment
Boehringer Ingelheim
BOXX Modular
Brammer Bio
Bristol Myers Squibb
Build It
Butler Manufacturing
Calitech Technical Services
Cambridge Cleanroom
Can-Trol Environmental
Caron
C-Cube
CE Group
CGT Catapult Stevenage
Chemgineering
Chempharm
Chrisleen Cleanroom Projects
CoCID Associates
Cipharm
Clean Air Flow
Clean Air Products
Clean Air Systems
Clean Air Technology
Clean3 Modular Cleanroom Systems
Clean Modules
Clean Room Depot
Clean Rooms International
Clean Rooms Plus
Clean Rooms West
Clean Zone Technology
CleanAir Solutions
Cleanetics
Cleanroom Ceiling Systems
Cleanroom Combination Group
Cleanroom Equipment
Cleanroom Solutions
Cleanroom Synergy
Cleanrooms Australia
Cleanrooms By United
Cleanrooms Containments
Cleanrooms Plus
CleanSpace
CleanZones
ClearSphere
Clenviron Technologies
Clestra Hauserman
Clestra Cleanroom
Codiak BioSciences
Commercial Structures corporation
Connect 2 Cleanrooms
CONSAB International
Cotaplan
CRB
CRDB Modular Cleanroom Solutions
Creative Foam
Cytiva
CytoImmune Therapeutics
Dagard
Daldrop
Dawson Group
Dec Group
Design Filtration Microzone
Dexcom
Dozie and Dozie’s Pharma
DPR Construction
Drees & Sommer
E- Pack Polymers
Ebtech Industrial Modular Building Solutions
Eli Lilly
Emergent BioSolutions
Enbloc
Envair Electrodyne
Environmental Systems Corporation
Envision Biotech
EPACK Prefab
Erytech Pharma
ESS Modular
Everest Composites
Expression Therapeutics
Extract Technology
Exyte
Fabtech
Ferring Pharnmaceuticals
Filtration Technology
Firmament Technology
Firs Bioengineering
Florida Cleanroom Systems
Flowstar Corporation
Fluor
FOSELEV
Galderma
Gallant Technologies
G-Con Manufacturing
GenCure
Genentech
Gerbig Engineering Company
Germfree
Gilead Sciences
GlaxoSmithKline
GMP Technical Solutions
GMPMax Pharma
Green Carrier Consultancy and Tech Solutions
GreenTech Venture
Grekon Infratech
Grifols
GSK
Guardtech Cleanrooms
Halco Products
HAZE comfort
Hectra Enviro Systems
Hemair Systems
HEMCO
HEPAire Products
Hermetel Oy
Hexakore
Hodess Construction
HOK
Holden
Hume Group MC
Huntair
Iberconcept
ICT Innovative Cleanroom Technologies
Iguna Pharmaceutical Technologies
Ingelyt
Innovation Expert Cleanrooms
Innovative Cleanroom Technologies
Innovative Pharmaintech
Innovators Cleantech
Instant Cleanroom Solutions
Instaspace
Instituto Butantan
Intact
Integrated Cleanroom Technologies
Integrity Cleanroom
IPM Technologies
IPS
IsoTech Design
Jacobs
JHL Biotech
Johnson & Johnson
Just Biotherapeutics
Just-Evotec Biologics
KABTech Corporation
Kaizen Airtech Solutions
Karlsruhe Institute of Technology
KELVIN
KeyPlants
Kingspan
Kleanzone Systems
Klimapharm Technologies
KTEC Cleanroom Systems
L7 Informatics
Lab in Boxes
Labover
LabRum
Labworks International
Lacy Construction
Lasco Services
Lennox Clean Air Technologies
Libbs Farmacêutica
Liberty Industries
LifeAire Systems
Lindner
Linesight
LM Air Technology
Longden Company
Lonza
LSB La Salle Blanche
MAK Clean Air Systems
Marion VA Medical Center
Mars Sterile Solutions
McLennan & Company
M. Davis & Sons
MDI
MECART
Medical Air Technology
Merck
Merit Holdings
Microbinc
MicroCool
MobileLabCompany
Modubuild
Moduguard
Modular Cleanrooms
Modular Devices
Modular Panel Systems
ModuleCo Pharma
Modulus Cleanrooms
Monmouth Scientific
MRC Cleanrooms
MRC Systems
MTX Contracts
Nano Clean
National Cancer Institute
National Institutes of Health
National Partitions
NCI Clean
NGS Cleanroom Solutions
Nicomac
NNE
Norwood Group
Novartis
Novo Nordisk
OCTANORM
Octapharma
Ori Biotech
Ortner Cleanrooms Unlimited
Oxford BioMedica
Pacific Environmental Technologies
Pall Biotech
Panel Built
Panelco
WSP
Parteco
PCCA
Pentec Health
Perotech Sciences
Pfizer
Pharma Access
Pharma Air Control Engineers
Pharma Air Modular Systems
Pharmacon
Pharmadule
Pharmaintech Turnkey Solutions
Piramal Pharma Solutions
Plascore
PortaFab
Porta-King Building Systems
Power And Motion
PPG Cleanrooms
Precise Engineering
Precision Air Technology
Precision Cleanrooms
Precision Extraction Solutions
ProCleanroom
Propart Modular
ProPharma Cleanrooms
Protech Solutions
Puracore
PureLinc Cleanrooms
Purever Tech
QleanAir Scandinavia
Riddhi Metals
Rinac
Ritterwand
Robert Soper
Roche
Rubius Therapeutics
Saakvee Technologies
Sai Seva Service
Sam Air Solution
Sanofi
Sapphire Cleanrooms
Saudi Bio
Schering Plough
Schilling Engineering
SciMed
SD Consulting
SGS
Shanghai HJ Modular Cleanroom
Shanghai Junshi Biosciences
SIC Experts
Siemens
Simplex Isolation Systems
Skanska
Skylark Engineering Technologies
SML Clean Room Solutions
SP Groups
Span Construction and Engineering
Speed Space
Srprefabs Modular Cleanroom
Starrco
Stefatos
Steriltech
STERIS Life Sciences
Stodec Products
Stragen Pharma
Strike Bio
Subzero Engineering
Swedish Modules
Syntec Airflow System
System Integration Technology
Systems BD
SZ Airkey Environmental Tech & Eng
Taiyo Pharma Tech
Takeda
Technical Air Products
Telstar Life Science Solutions
Terra Universal
Zhejiang Teruisi Pharmaceutical
TEVA Pharmceutical
The Softwall Shop
Thrius Pharma Expertize
Total Precision Cleanrooms Aust
Touchlight
Travis CleanAir
CTriumph Modular
TrueBinding
Tudela International
Ultrapure Technology
Unibio
UNIFIED Technical Solutions
Unikelvin Ventures
United Partition Systems
Univercells
Universal Technical Solutions
University of Tennessee Health Science Center
Unizima
Vanrx Pharmasystems
Vedaa Prefab Technologies
Veltek Associates
Vernick
Viessmann Technologies
Vitma Positech
VK Clean Rooms
VRP Cleanroom Systems
W.W. Cannon
Wacker Chemie
Walvax
Weaver Technologies
Westbury Cleanrooms
Western Environmental Corporation
Whitenair Technologies
WHP Engineering
WuXi Vaccines
Xytel
YRS Enterprise
Zeton
Ziccum

Source 1: https://www.sciencedirect.com/topics/engineering/modular-construction
Source 2: https://www.pall.co.in/en/biotech/blog/modular-biomanufacturing.html

PRICING DETAILS

Single-User License USD 4,799

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

One Location Site License USD 6,999

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

Department License USD 10,599

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

Enterprise License USD 17,999

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com

Modular Construction Market

Modular Construction Overview

Key Market Insights

Key Advantages Offered by Modular Facilities

Current Market Landscape of Modular Facility and Modular Cleanroom Manufacturers

Key Drivers in the Modular Construction Market: Pharmaceutical Industry Adopting Modular Manufacturing

Global Market Size for Pharmaceutical Modular Construction

Leading Modular Facilities and Modular Cleanroom Manufacturers

Recent Developments in Modular Construction Market:

Scope of the Report

Frequently Asked Questions

Question 1: What is modular manufacturing?

Question 2: What is the modular facility manufacturing process?

Question 3: Which material is most widely used for the modular construction of pharmaceutical facilities?

Question 4: Which healthcare sector is rapidly employing modular facilities?

Question 5: Which types of partnerships are inked by modular facility providers?

Question 6: How is the modular construction market within pharmaceutical industry likely to grow in the future?

Question 7: Which region is leading the modular construction market (biotechnology / pharmaceutical industry)?

Table Of Contents

List Of Figures

List Of Tables

List Of Companies

Single-User License USD 4,799

One Location Site License USD 6,999

Department License USD 10,599

Enterprise License USD 17,999

YOU MAY ALSO LIKE

Cryopreservation Bags and Freezing Bags - Current Scenario and Future Trends

The Future Of Healthcare: Wearable Injectors Unveiled

Market Insights Reports

Indication Specific Reports

Modular Construction Market

Modular Construction Overview

Key Market Insights

Key Advantages Offered by Modular Facilities

Current Market Landscape of Modular Facility and Modular Cleanroom Manufacturers

Key Drivers in the Modular Construction Market: Pharmaceutical Industry Adopting Modular Manufacturing

Global Market Size for Pharmaceutical Modular Construction

Leading Modular Facilities and Modular Cleanroom Manufacturers

Recent Developments in Modular Construction Market:

Scope of the Report

Frequently Asked Questions

Question 1: What is modular manufacturing?

Question 2: What is the modular facility manufacturing process?

Question 3: Which material is most widely used for the modular construction of pharmaceutical facilities?

Question 4: Which healthcare sector is rapidly employing modular facilities?

Question 5: Which types of partnerships are inked by modular facility providers?

Question 6: How is the modular construction market within pharmaceutical industry likely to grow in the future?

Question 7: Which region is leading the modular construction market (biotechnology / pharmaceutical industry)?

Table Of Contents

List Of Figures

List Of Tables

List Of Companies

Single-User License USD 4,799

One Location Site License USD 6,999

Department License USD 10,599

Enterprise License USD 17,999

YOU MAY ALSO LIKE

Cryopreservation Bags and Freezing Bags Market

Plasmid DNA Manufacturing Market

Single Use Bioreactors Market

Cryopreservation Bags and Freezing Bags - Current Scenario and Future Trends

The Future Of Healthcare: Wearable Injectors Unveiled